GLP-1 drugs such as Ozempic have gained significant popularity, particularly as weight-loss aids. Despite their benefits, there are some drawbacks to consider, including the potential for rebound weight gain and loose skin. When it comes to their side effects in older individuals, limited information is available. Nonetheless, it is worth noting that people over the age of 65 generally tend to be more susceptible to drug side effects.
Experts emphasize that with appropriate supervision, these drugs can be "truly remarkable" for this specific population. Careful monitoring and individualized treatment plans are essential to ensure the safety and effectiveness of GLP-1 drugs in older adults.
GLP-1 drugs encompass a range of medications, including various brands of semaglutide (Ozempic, Rybelsus, Wegovy), dulaglutide (Trulicity), exenatide (Bydureon, Byetta), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), and tirzepatide (Mounjaro). Typically administered through injections, these drugs work by mimicking glucagon-like peptide 1, stimulating the pancreas to produce more insulin after meals, thereby reducing blood sugar levels in individuals with Type 2 diabetes.
Aside from their effectiveness in managing diabetes, Ozempic and other GLP-1 drugs have gained popularity as weight-loss aids, with endorsements from celebrities like Dolores Catania and Charles Barkley.
However, as the usage of these drugs increases, certain drawbacks have come to light, including the occurrence of loose skin (referred to as "Ozempic butt") and rebound weight gain.
Furthermore, there are rare but serious side effects associated with these drugs, such as pancreatitis.
One aspect that remains unclear is how these medications might impact adults aged 65 and older who use them on a long-term basis. Clinical trials for these drugs have not included substantial numbers of older adults, leading to a lack of available data, as reported by The Washington Post.
The National Institute on Aging acknowledges that older adults often use multiple medications and have multiple medical conditions, which puts them at a higher risk of experiencing drug side effects.
What are the potential risks of medications such as Ozempic in older adults?
According to Dina Peralta-Reich, M.D., FAAP, FOMA, and Director of New York Weight Wellness Medicine, there are potential risks associated with medications like Ozempic in older adults, particularly those over the age of 65. One significant concern is dehydration, which can be challenging to monitor. Dehydration may lead to dizziness, falls, fainting, and even fractures.
Furthermore, older individuals might experience more pronounced gastrointestinal side effects, such as nausea and vomiting, which could increase the risk of dehydration, weakness, or nutritional deficiencies.
To address these potential risks, Peralta-Reich emphasizes the importance of specialist supervision for anyone using these medications, particularly in the context of obesity medicine. The objective is to ensure successful weight loss while safeguarding against muscle mass loss.
Jill Barat, Pharm.D., a licensed pharmacist with Pharmedico Pharmacy, warns that muscle loss can be particularly dangerous for older individuals as it increases the risk of falls and subsequent fractures.
Close monitoring is crucial for older patients, especially if they have other health conditions like high blood pressure, diabetes, and hormonal deficiencies, as dosage adjustments may be necessary throughout the course of treatment. As a person's weight decreases, their dosage should also be appropriately adjusted to match their current body size.
What the experts think about using GLP-1 drugs
According to Peralta-Reich, these drugs are "truly remarkable" when patients receive oversight from a board-certified obesity medicine specialist. She emphasized that regardless of age, the risks associated with being overweight or obese are significant. Effectively reducing body fat percentage and visceral fat can substantially lower the chances of developing other health issues. Dr. Michael Russo, a Bariatric Surgeon at Smart Dimensions in Orange County, California, cautioned that drugs like Ozempic are not a quick fix. To achieve the best results and minimize the chance of weight regain in the future, lifestyle changes should accompany medication use. As a word of encouragement, Peralta-Reich noted that being 65 years old is no longer considered old, and it presents an excellent opportunity to take charge of one's health and weight in a safe and effective manner. She emphasized that embracing a healthier lifestyle can lead to positive outcomes at any age!
Other effective alternatives to GLP-1 drugs
However, it is important to mention that drugs like Ozempic may not always be accessible to patients due to their high cost and limited coverage by insurance companies, particularly for weight loss purposes.
Regarding the management of Type 2 diabetes, Dr. Kezia Joy, Medical Content Advisor for Welzo, highlighted several alternatives to GLP-1 drugs, including: [List the alternatives here.]
1. Metformin 2. DPP-4 inhibitors 3. SGLT2 inhibitors 4. Insulin therapy
Nevertheless, she emphasized, "Lifestyle modifications, such as adopting a healthy diet, engaging in regular physical activity, and managing weight, continue to be the foundation of diabetes management regardless of age." Russo further stated that concerning weight loss, individuals should be aware that there are various medication options, endoscopic procedures, and highly safe weight-loss surgery alternatives to consider.
GLP-1 drugs such as Ozempic have gained significant popularity, particularly as weight-loss aids. However, they do come with certain drawbacks, such as rebound weight gain and the possibility of loose skin.
Regarding their side effects in older individuals, there is limited information available. Nevertheless, it is recognized that people over the age of 65 generally tend to be more susceptible to drug side effects in general.
Despite these considerations, experts assert that with proper supervision, these drugs can be "truly remarkable" in this population. Proper monitoring and individualized treatment plans are essential to ensure the safe and effective use of GLP-1 drugs in older adults.
%20(1)-Photoroom.png)